Efficacy and safety of once-daily QVA149 compared with twice-daily salmeterol–fluticasone in patients with chronic obstructive pulmonary disease (ILLUMINATE): a randomised, double-blind, parallel group study
Author:
Publisher
Elsevier BV
Subject
Pulmonary and Respiratory Medicine
Reference29 articles.
1. Inhaled corticosteroids in COPD: the case against;Suissa;Eur Respir J,2009
2. General practitioners' adherence to the COPD GOLD guidelines: baseline data of the Swiss COPD Cohort Study;Jochmann;Swiss Med Wkly,2010
3. Practice patterns in the management of chronic obstructive pulmonary disease in primary practice: the CAGE study;Bourbeau;Can Respir J,2008
4. Formoterol mono- and combination therapy with tiotropium in patients with COPD: a 6-month study;Vogelmeier;Respir Med,2008
5. The scientific rationale for combining long-acting beta2-agonists and muscarinic antagonists in COPD;Cazzola;Pulm Pharmacol Ther,2010
Cited by 263 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Overuse of long-acting β 2 -agonist/inhaled corticosteroids in patients with chronic obstructive pulmonary disease: time to rethink prescribing patterns;Postgraduate Medicine;2023-11-17
2. The Clinical Characteristics and Outcomes in Non-Frequent Exacerbation Patients with Chronic Obstructive Pulmonary Disease in the Chinese Population;International Journal of Chronic Obstructive Pulmonary Disease;2023-08
3. Association of IL4RA polymorphism in predicting susceptibility toward chronic obstructive pulmonary disease;Pharmacogenomics;2023-07
4. Chronic Obstructive Pulmonary Disease Exacerbations and Pneumonia Hospitalizations Among New Users of Combination Maintenance Inhalers;JAMA Internal Medicine;2023-07-01
5. Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease;Cochrane Database of Systematic Reviews;2023-06-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3